Announced Mon, 29 Jun · 16:45 IST
Trading window closed for Q1 FY27 results
Compliance View source PDF
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.6%1-day move
₹166.50
prior close
₹167.48
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.3-0.2-0.3+1.6+1.4+5.5+7.0+5.1+3.4+11.3———
Up moveDown movePending
AI summary
Piramal Pharma has closed its trading window from July 1, 2026, until 48 hours after the declaration of unaudited financial results for Q1 FY27 (quarter ending June 30, 2026). The closure applies to all designated persons and their immediate relatives under the company's insider trading code. The board meeting date to approve the results will be announced later.
Likely market impact
Routine compliance filing. No direct impact on shareholders. Signals upcoming Q1 FY27 earnings announcement.